KYMR - Kymera Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KYMR is currently covered by 19 analysts with an average price target of $111.44. This is a potential upside of $27.95 (33.48%) from yesterday's end of day stock price of $83.49.

Kymera Therapeutics's activity chart (see below) currently has 172 price targets and 150 ratings on display. The stock rating distribution of KYMR is 96.3% BUY and 3.7% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 86.38% with an average time for these price targets to be met of 330.9 days.

Highest price target for KYMR is $134, Lowest price target is $52, average price target is $108.94.

Most recent stock forecast was given by GEOFF MEACHAM from CITI on 02-Mar-2026. First documented stock forecast 15-Sep-2020.

Currently out of the existing stock ratings of KYMR, 52 are a BUY (96.3%), 2 are a HOLD (3.7%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Jun-2025

$120

$36.51 (43.73%)

$80

6 days ago
(02-Mar-2026)

10/11 (90.91%)

$28.65 (31.36%)

238

Buy Since 17-Sep-2025

$133

$49.51 (59.30%)

$119

1 months 8 days ago
(28-Jan-2026)

2/4 (50%)

$61.84 (86.90%)

162

Buy Since 03-Jun-2025

$117

$33.51 (40.14%)

$80

2 months 14 days ago
(22-Dec-2025)

10/11 (90.91%)

$32.65 (38.71%)

303

Buy Since 16-Sep-2025

$103

$19.51 (23.37%)

$70

2 months 20 days ago
(16-Dec-2025)

1/2 (50%)

$18.81 (22.34%)

83

Buy Since 04-Dec-2020

$134

$50.51 (60.50%)

$70

2 months 26 days ago
(10-Dec-2025)

11/12 (91.67%)

$44.11 (49.07%)

240

Show more analysts

Please expand the browser size to see the chart

What is KYMR (Kymera Therapeutics) average time for price targets to be met?

On average it took 330.9 days on average for the stock forecasts to be realized with a an average price target met ratio 86.38

Which analyst has the current highest performing score on KYMR (Kymera Therapeutics) with a proven track record?

ELIANA MERLE

Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?

Eliana Merle works at BARCLAYS and has 7 price targets and 5 ratings on KYMR

Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?

Andrew Fein with highest potential upside - $50.51

Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?

Vikram Purohit with lowest potential downside - -$49.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?